With regard to prostate cancer, one report suggests that CDK11p58 expression is reduced in primary prostate cancer tissue; however, neither kinase activity nor level of activation of CDK11p58 in metastatic prostate cancer was tested [24]. Here, CDK11B is linked to metastatic prostate carcinoma.